1. Home
  2. LPCN vs FEAM Comparison

LPCN vs FEAM Comparison

Compare LPCN & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • FEAM
  • Stock Information
  • Founded
  • LPCN 1997
  • FEAM 2016
  • Country
  • LPCN United States
  • FEAM United States
  • Employees
  • LPCN N/A
  • FEAM N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • LPCN Health Care
  • FEAM Industrials
  • Exchange
  • LPCN Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • LPCN 36.8M
  • FEAM 32.4M
  • IPO Year
  • LPCN N/A
  • FEAM N/A
  • Fundamental
  • Price
  • LPCN $5.16
  • FEAM $0.50
  • Analyst Decision
  • LPCN Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • LPCN 1
  • FEAM 3
  • Target Price
  • LPCN $10.00
  • FEAM $4.58
  • AVG Volume (30 Days)
  • LPCN 26.5K
  • FEAM 65.9K
  • Earning Date
  • LPCN 11-07-2024
  • FEAM 11-13-2024
  • Dividend Yield
  • LPCN N/A
  • FEAM N/A
  • EPS Growth
  • LPCN N/A
  • FEAM N/A
  • EPS
  • LPCN N/A
  • FEAM N/A
  • Revenue
  • LPCN $7,922,926.00
  • FEAM N/A
  • Revenue This Year
  • LPCN N/A
  • FEAM N/A
  • Revenue Next Year
  • LPCN N/A
  • FEAM $578.23
  • P/E Ratio
  • LPCN N/A
  • FEAM N/A
  • Revenue Growth
  • LPCN N/A
  • FEAM N/A
  • 52 Week Low
  • LPCN $2.38
  • FEAM $0.40
  • 52 Week High
  • LPCN $11.79
  • FEAM $2.48
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 49.88
  • FEAM 50.82
  • Support Level
  • LPCN $4.64
  • FEAM $0.43
  • Resistance Level
  • LPCN $5.40
  • FEAM $0.48
  • Average True Range (ATR)
  • LPCN 0.51
  • FEAM 0.05
  • MACD
  • LPCN -0.07
  • FEAM 0.01
  • Stochastic Oscillator
  • LPCN 34.48
  • FEAM 57.77

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: